theory clinical_35_5
imports Main


begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  CTNNB1Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  InPatient :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  EntailedBy :: "event ⇒ event ⇒ bool"
  PresenceOf :: "event ⇒ entity ⇒ bool"
  NotchInhibitor :: "entity ⇒ bool"
  Treat :: "event ⇒ bool"
  EffectivenessOf :: "event ⇒ entity ⇒ bool"
  TreatmentWith :: "event ⇒ entity ⇒ bool"
  Inhibitor :: "event ⇒ entity ⇒ bool"
  WithMutation :: "event ⇒ entity ⇒ bool"
  Implies :: "event ⇒ bool"
  ActivationOf :: "event ⇒ entity ⇒ bool"
  SuggestedBy :: "event ⇒ event ⇒ bool"
  PotentialEffectivenessOf :: "event ⇒ entity ⇒ bool"
  GivenPatient :: "event ⇒ entity ⇒ bool"

(* Explanation 1: The activation of a patient with CTNNB1 mutations is entailed by the presence of activating CTNNB1 mutations in the patient. *)
axiomatization where
  explanation_1: "∀x y z e. Patient x ∧ CTNNB1Mutation y ∧ Activating y ∧ InPatient e ∧ Agent e y ∧ Patient e x ∧ EntailedBy e z ∧ PresenceOf z y ∧ InPatient z x"

(* Explanation 2: The effectiveness of a specific Notch inhibitor in treating a patient is entailed by the effectiveness of the Notch inhibitor and the treatment of the patient with the inhibitor. *)
axiomatization where
  explanation_2: "∀x y z e1 e2. NotchInhibitor x ∧ Patient y ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ EntailedBy e1 z ∧ EffectivenessOf z x ∧ TreatmentWith z y ∧ Inhibitor z x"

(* Explanation 3: If a specific Notch inhibitor is effective in treating a patient with activating CTNNB1 mutations, it implies the activation of the patient and the effectiveness of the inhibitor. *)
axiomatization where
  explanation_3: "∀x y z e1 e2. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithMutation y z ⟶ (Implies e2 ∧ ActivationOf e2 y ∧ EffectivenessOf e2 x)"

(* Explanation 4: The potential effectiveness of Notch inhibitors in treating patients with activating CTNNB1 mutations is suggested by the effectiveness of a specific Notch inhibitor in treating a given patient with such mutations. *)
axiomatization where
  explanation_4: "∀x y z e1 e2. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e1 ∧ Agent e1 x ∧ Patient e1 y ∧ WithMutation y z ∧ SuggestedBy e2 ∧ PotentialEffectivenessOf e2 x ∧ GivenPatient e2 y ∧ WithMutation y z"


theorem hypothesis:
 assumes asm: "NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z"
  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
 shows "∃x y z e. NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z ∧ Treat e ∧ Agent e x ∧ Patient e y ∧ WithMutation y z"
proof -
  (* From the premise, we have the information about the Notch inhibitor, patient, CTNNB1 mutation, and activation. *)
  from asm have "NotchInhibitor x ∧ Patient y ∧ CTNNB1Mutation z ∧ Activating z" <ATP>
  (* We can use Explanation 3 to infer the activation of the patient and the effectiveness of the inhibitor. *)
  from explanation_3 and asm have "Implies e2 ∧ ActivationOf e2 y ∧ EffectivenessOf e2 x" <ATP>
  (* Since we have the activation of the patient and the effectiveness of the inhibitor, we can derive the treatment of the patient with the inhibitor. *)
  then have "Treat e2 ∧ Agent e2 x ∧ Patient e2 y ∧ WithMutation y z" <ATP>
  then show ?thesis <ATP>
qed

end
